Quantcast
Home / Practice Areas / Personal Injury and Tort / Jury selection begins in Neurontin suicide trial

Jury selection begins in Neurontin suicide trial

BOSTON - Jury selection began Monday in the second wrongful death trial alleging Pfizer's off-label promotion of its anti-epilepsy drug Neurontin caused a patient to commit suicide.